Ingrid Jakobsen Falk
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 15, 2022
Early changes in gene expression profiles in AML patients during induction chemotherapy.Ingrid Jakobsen, Max Sundkvist, Niclas Björn
|Feb 08, 2022
The association of four genetic variants with myelosuppression in gemcitabine-treated Japanese is not evident in gemcitabine/carboplatin-treated Swedes.Niclas Björn, Ingrid Jakobsen, Chihiro Udagawa
|Aug 05, 2020
Activation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure.Anna Åstrand, Svante Vikingsson, Ingrid Jakobsen
|May 20, 2020
Single-Cell RNA Sequencing of Hematopoietic Stem and Progenitor Cells Treated with Gemcitabine and Carboplatin.Niclas Björn, Ingrid Jakobsen, Kourosh Lotfi
|Mar 06, 2018
ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer Patients.Niclas Björn, Ingrid Jakobsen Falk, Ignace Vergote
|Nov 28, 2017
Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.Ingrid Jakobsen Falk, Johan Lund, Henrik Gréen
Pageof 1
